This inventor holds 11 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Taro Pharmaceutical Industries Limited, Dexcel Pharma Technologies Ltd., Taro Pharmaceuticals Industries. Active years: 2019-2025.
Location History:
- Tel Aviv, IL (2019 - 2023)
- Haifa, IL (2023)
Company Filing History:
5 out of 38 
4 out of 20 
1 out of 7 Years Active: 2019-2025
Title: **Innovative Contributions of Inventor Ron Schlinger**
Introduction
Ron Schlinger, an accomplished inventor based in Tel Aviv, Israel, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 11 patents, his innovative spirit continues to drive advancements in topical formulations.
Latest Patents
Among his latest contributions, Schlinger has developed topical Montelukast formulations. These formulations include a topical emulsion containing about 0.5% to about 10% Montelukast or its pharmaceutically acceptable salts, combined with about 0.4% to about 4% carbomer. Notably, the particles comprising Montelukast in the emulsion achieve a D90 of less than 50 μm, ensuring a homogenous dispersion within a pH range of about 3.0 to about 6.5. Additionally, his patents detail a topical gel formulation consisting of about 0.5% to about 10% Montelukast, approximately 0.2% to about 8% cellulose polymer, and a significant portion (about 80% to about 95%) of amphiphilic compounds, with less than 4% water content.
Career Highlights
Schlinger has had a dynamic career with notable stints in established pharmaceutical companies, including Taro Pharmaceutical Industries Limited and Dexcel Pharma Technologies Ltd. His work in these organizations has profoundly shaped his research and development approach, making him a significant player in the pharmaceutical industry.
Collaborations
Throughout his career, Schlinger has collaborated with several esteemed professionals, including Avi Avramoff and Helena Shifrin. These collaborations have contributed to his innovative developments, allowing for a fusion of ideas that enhance the effectiveness of his inventions.
Conclusion
Ron Schlinger stands out as an influential inventor whose contributions to topical formulations have the potential to improve patient care significantly. With a robust patent portfolio and collaborations with talented professionals, his future endeavors are eagerly anticipated within the pharmaceutical landscape.